SEC Comment Letter 0000000000-23-000837 to Vitro Biopharma, Inc. (VTRO) (CIK 0000793171)

Vitro Biopharma, Inc. (VTRO) (CIK 0000793171)
Date: Jan. 25, 2023 · CIK: 0000793171 · Accession: 0000000000-23-000837

View on Edgar

AI Filing Summary & Sentiment

File numbers found in text: 000-17378

Date

January 25, 2023

Author

Not clearly detected

Form

UPLOAD

Company

Vitro Biopharma, Inc. (VTRO) (CIK 0000793171)

Letter

United States securities and exchange commission logo January 25, 2023 Christopher Furman Chief Executive Officer Vitro Biopharma, Inc. 3200 Cherry Creek Drive Suite 720 Denver, CO 80209 Re:Vitro Biopharma, Inc. Amendment No. 3 to Registration Statement on Form 10 Filed on January 19, 2023 File No. 000-17378 Dear Christopher Furman: We have completed our review of your filing. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Sincerely, Division of Corporation Finance Office of Life Sciences cc: David J. Babiarz

Show Raw Text

United States securities and exchange commission logo
January 25, 2023
Christopher Furman
Chief Executive Officer
Vitro Biopharma, Inc.
3200 Cherry Creek Drive
Suite 720
Denver, CO 80209
Re:Vitro Biopharma, Inc.
Amendment No. 3 to Registration Statement on Form 10
Filed on January 19, 2023
File No. 000-17378
Dear Christopher Furman:
            We have completed our review of your filing.  We remind you that the company and its
management are responsible for the accuracy and adequacy of their disclosures, notwithstanding
any review, comments, action or absence of action by the staff.
Sincerely,
Division of Corporation Finance
Office of Life Sciences
cc:       David J. Babiarz

SecProbe.io